Summit Partners Public Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Hold
0
71
2020
Q1
Hold
0
60
2019
Q4
Sell
-125,000
Closed -$5.12M 70
2019
Q3
$5.12M Buy
+125,000
New +$5.12M 0.5% 46